top of page

About Us
Journal
Platform
Pipeline
Engage
Contact

Canurta Website Images.jpg

Canurta Journal

A collection of news, scientific papers and impact across industry, academia and events.

All Posts
Research
Events
Awards
News
Blog
Newsletter

Canurta Therapeutics at the 35th International Symposium on ALS/MND

Canurta Therapeutics at the 35th International Symposium on ALS/MND

Canurta Therapeutics at the 35th International Symposium on ALS/MND

Showcasing Innovative Research on ALS On December 7, 2024, Canurta Therapeutics attended the 35th International Symposium on ALS/MND,...

Jan 22

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401

Canurta Therapeutics is pleased to share that CEO Akeem Gardner participated in the ACT (Accelerating Clinical Trials) Canada Consortium...

Oct 10, 2024

Reflecting on the ALS Drug Development Summit in Boston

Reflecting on the ALS Drug Development Summit in Boston

Reflecting on the ALS Drug Development Summit in Boston

This week, I had the opportunity to attend the ALS Drug Development Summit in Boston, an event that brought together the brightest minds...

May 24, 2024

Transforming Rare Polyphenols into Botanical Drugs

Stay connected & receive updates on new discoveries, product innovation and more.

Yes, I consent to receiving emails from Canurta Therapeutics about news, updates, and relevant content. I understand I can unsubscribe at any time.

Thank you for subscribing.

© 2025 Canurta, Inc. All rights reserved.

bottom of page